Maxigesic IV + IV Acetaminophen + IV Ibuprofen + Placebo IV
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Post Operative Pain
Conditions
Post Operative Pain
Trial Timeline
Oct 26, 2016 → Sep 15, 2017
NCT ID
NCT02689063About Maxigesic IV + IV Acetaminophen + IV Ibuprofen + Placebo IV
Maxigesic IV + IV Acetaminophen + IV Ibuprofen + Placebo IV is a phase 3 stage product being developed by AFT Pharmaceuticals for Post Operative Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02689063. Target conditions include Post Operative Pain.
What happened to similar drugs?
20 of 20 similar drugs in Post Operative Pain were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02689063 | Phase 3 | Completed |
Competing Products
20 competing products in Post Operative Pain